Primary resistance of a novel hepatitis B virus variant to adefovir

被引：1
|
作者：
Schildgen, O.
Sirma, H.
Funk, A.
Wend, U. C.
Hartman, H.
Olotu, C.
Helm, M.
Willems, Wr.
Will, H.
Gerlich, W. H.
机构：
[1] Univ Bonn, Inst Med Microbiol & Immunol, D-5300 Bonn, Germany
[2] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany
[3] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany
[4] Univ Giessen, Inst Med Virol, Giessen, Germany
[5] Univ Gottingen, Dept Pathol, D-3400 Gottingen, Germany
[6] Practice Abelein Helm, Nurnberg, Germany
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80511-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
511
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [41] Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes.
    Köck, J
    Baumert, TF
    Blum, HE
    von Weizsäcker, F
    HEPATOLOGY, 2003, 38 (04) : 718A - 718A
  • [42] Reappearance of wild-type hepatitis B virus during adefovir monotherapy for patients with lamivudine resistance
    Hann, HW
    Platt, JL
    HEPATOLOGY, 2005, 42 (04) : 574A - 574A
  • [43] The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil
    Liu, Y.
    Li, X.
    Xin, S.
    Xu, Z.
    Chen, R.
    Yang, J.
    Liu, L.
    Wong, V. W-S
    Yang, D.
    Chan, H. L-Y
    Xu, D.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (03) : 328 - 334
  • [44] Polymorphisms which may be responsible for primary treatment failure to adefovir in distinct hepatitis B virus genotypes
    Soriano, V.
    Sheldon, J.
    Madejon, A.
    Bottecchia, M.
    Garcia-Samaniego, J.
    Barreiro, P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S264 - S264
  • [45] Hepatitis B virus mutations potentially conferring adefovir/tenofovir resistance in treatment-naive patients
    Pastor, Rebecca
    Habersetzer, Francois
    Fafi-Kremer, Samira
    Doffoel, Michel
    Baumert, Thomas F.
    Gut, Jean-Pierre
    Stoll-Keller, Francoise
    Schvoerer, Evelyne
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (06) : 753 - 755
  • [46] The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil
    Liu, Yan
    Li, Xiaodong
    Xin, ShaoJie
    Xu, Zhihui
    Chen, Rongjuan
    Yang, Jing
    Chen, Li
    Wong, Vincent W.
    Yang, Dongliang
    Chan, Henry Lik-Yuen
    Xu, Dongping
    HEPATOLOGY, 2014, 60 : 1039A - 1039A
  • [47] Resistance to adefovir dipivoxil in lamivudine resistant chronic hepatitis B patients treated with adefovir dipivoxil
    Yeon, J. E.
    Yoo, W.
    Hong, S. P.
    Chang, Y. J.
    Yu, S. K.
    Kim, J. H.
    Seo, Y. S.
    Chung, H. J.
    Moon, M. S.
    Kim, S-O
    Byun, K. S.
    Lee, C. H.
    GUT, 2006, 55 (10) : 1488 - 1495
  • [48] The combination of lamivudine and adefovir prevents both lamivudine and adefovir resistance in patients with chronic hepatitis B
    Hezode, Christophe
    Dhalluin-Venier, Valerie
    Chevaliez, Stephane
    Roudot-Thoraval, Francoise
    Mallat, Ariane
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2008, 134 (04) : A810 - A810
  • [49] Adefovir dipivoxil/lamivudineDevelopement of adefovir dipivoxil and lamivudine resistance in hepatitis B cirrhosis: case report
    Reactions Weekly, 2017, 1678 (1) : 14 - 14
  • [50] A novel baseline hepatitis B virus sequencing-based strategy for predicting adefovir antiviral response
    Wang, Yu-Wei
    Shan, Xuefeng
    Huang, Yao
    Deng, Haijun
    Huang, Wen-Xiang
    Zhang, Da-Zhi
    Chen, Juan
    Tang, Ni
    Shan, You-Lan
    Guo, Jin-Jun
    Huang, Ailong
    INFECTION GENETICS AND EVOLUTION, 2015, 33 : 269 - 276
12345